Shares of Alembic Pharmaceuticals fell 1.57% to Rs 952.10 on the BSE. Mumbai, Aug. 5 -- Revenue from operations grew 9.54% year on year (YoY) to Rs 1,710.72 crore in the quarter ended 30 June 2025.

US stock indices showed resilience on Tuesday, edging higher amid economic uncertainty and tariff concerns. Optimism ...

Wall Street is holding steadier following its see-saw ride that bracketed the weekend. The S&P 500 was up 0.1% in early ...

Global stock markets rose Tuesday as investors grew increasingly confident that the US Federal Reserve will cut interest ...

Wall Street stock indexes were lower on Tuesday following weaker than expected U.S. economic data, as equities in Europe and ...

U.S. stocks ended sharply higher on Monday, with all three major indexes recording their biggest daily percentage gains since May 27, after the prior session saw massive losses, following concerns ...

The exits mark the end of a high-profile Japanese-Chinese investor chapter in Paytm’s journey, from becoming India’s most ...

One country is clashing with the U.S., the other racing to appease Washington. Both approaches are being tested ahead of a ...

US Stock Markets were also still watching if Trump will decide to extend a trade truce with China that expires on August 12, ...

The key equity benchmarks ended with moderate cuts today, pressured by mixed Q1 earnings and renewed global jitters after U.S. President Donald Trump threatened steep tariffs on India. The Nifty ...

Welcure Drugs & Pharmaceuticals' penny stock surged 660% over five years and 164% in two years. It hit a 5% upper circuit on ...

Tech company earnings appear to be driving the stock markets upward today after Palantir delivered a massive quarter after ...